CURRENT ISSUE Current Issue Cover
VOL 8 • NO 2 MAR/APR 2017
IN THIS ISSUE

Protecting Against Sun Exposure: Which SPF Will You Recommend?

Pamela Hallquist Viale, RN, MS, CNS, ANP

Advanced Care Provider and Nursing Approach to Assessment and Management of Immunotherapy-Related Dermatologic Adverse Events

Kathryn Ciccolini,(1) BSN, RN, OCN®, DNC, Anna Skripnik Lucas,(1) MSN, RN, DNC, FNP-BC, Alyona Weinstein,(2) MSN, FNP-BC, and Mario Lacouture,(1) MD

Managing Constipation in Adults With Cancer

Rita J. Wickham, PhD, RN, AOCN®

Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer

Karlyn Porter,(1) PA-C, MPAS, and Margaret Quinn Rosenzweig,(2) PhD, FNP-BC, AOCNP®, FAAN

 
Section Seperator

TODAY'S NEWS

FDA Approves Maintenance Niraparib for R...

The U.S. Food and Drug Administration has approved...

ASCO and Cancer Care Ontario Update Guid...

ASCO and Cancer Care Ontario have issued a joint c...

New Study Finds That Most Cancer Mutatio...

Data from a new study published by Tomasetti and V...

Hypofractionated vs Conventional Radioth...

Hypofractionated radiotherapy was noninferior to s...

Impact of 70-Gene Signature on Adjuvant ...

In a Dutch observational study reported in the Jou...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Continuing Education Information

A continuing education article for NPs, clinical nurse specialists, advanced degree nurses, and oncology and hematology nurses....

Use of Diagnostic Tests in Advanced NSCLC

Interpreting pathology reports as well as routine imaging studies is one of the many roles of the advanced practitioner (AP) in oncology...

Brief Introduction to Cognitive Behavioral Therapy

APs are familiar with multidisciplinary and collaborative care; many practice in settings where they refer patients...

Osimertinib: A Novel Therapeutic Option for T790M

Lung cancer is the leading cause of cancer death for men and women in the U.S...

NCCN Imaging Appropriate Use Criteria

The NCCN website has an evidence-based tool called the NCCN Imaging Appropriate Use Criteria (AUC) Compendium™ ...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Analysis of High-Risk Subgroup in ASSURE...

In an analysis of the phase III ASSURE trial repor...

New Supportive Care Resources From NCCN ...

To empower patients confronting distress after a c...

Major Pharmaceutical Companies Collabora...

The National Comprehensive Cancer Network® (NC...

Delays in Radiotherapy for Head and Neck...

Interruption of radiotherapy for head and neck can...

Celecoxib or Celecoxib/Zoledronic Acid i...

As reported by Mason et al in the <em>Journa...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me